Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
98 hedge funds and large institutions have $598M invested in Infinity Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 13 closing their positions.
16% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 32
5% more capital invested
Capital invested by funds: $570M → $598M (+$28.2M)
0% more funds holding
Funds holding: 98 → 98 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
57% less call options, than puts
Call options by funds: $4.84M | Put options by funds: $11.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.91M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.77M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.76M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$3.58M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$3.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$15M |
| 2 |
DM
Deerfield Management
New York
|
-$8.01M |
| 3 |
VAM
Visium Asset Management
New York
|
-$5.35M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.67M |
| 5 |
Renaissance Technologies
New York
|
-$3.12M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
JP Morgan Chase
New York
| – | -$2.12M | -177,848 | Closed |
|
|
CNB
102
City National Bank
Beverly Hills,
California
| – | -$373K | -31,400 | Closed |
|
103
Axa
Paris,
France
| – | -$308K | -25,923 | Closed |
|
|
TAM
104
Tocqueville Asset Management
New York
| – | -$240K | -20,200 | Closed |
|
105
Jane Street
New York
| – | -$223K | -18,736 | Closed |
|
|
PC
106
Passport Capital
San Francisco,
California
| – | -$197K | -16,556 | Closed |
|
|
SCM
107
Stevens Capital Management
Radnor,
Pennsylvania
| – | -$165K | -13,841 | Closed |
|
|
IAM
108
Iridian Asset Management
Westport,
Connecticut
| – | -$159K | -13,350 | Closed |
|
|
TRCT
109
Tower Research Capital (TRC)
New York
| – | -$19K | -1,623 | Closed |
|
|
MAA
110
Managed Account Advisors
Jersey City,
New Jersey
| – | -$6K | -485 | Closed |
|
|
LTFS
111
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | +$406 | +39 | New |
|
INFI Hedge Fund Activity: Q2 2014 in Review
98 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q2 2014, worth a combined $598M — up 4.9% from $570M a quarter earlier.
Fund positioning in INFI was balanced in Q2 2014: 13 funds opened new positions, 13 closed out, 37 added to existing stakes and 32 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $4.91M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $15M sold.
- 98 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $598M of Infinity Pharmaceuticals, Inc. stock for Q2 2014, up 4.9% quarter-over-quarter.
- 13 funds opened new Infinity Pharmaceuticals, Inc. positions in Q2 2014 and 13 closed out, a net change of 0 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q2 2014 was Fidelity Investments, an estimated $4.91M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q2 2014 was Consonance Capital Management, an estimated $15M sold.
Based on aggregated 13F filings for Q2 2014.